{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:11:03Z","timestamp":1784034663747,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of health, Abu Dhabi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-026-00239-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:27:57Z","timestamp":1784032077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes and GVHD in allogeneic hematopoietic cell transplantation abroad: a 14-year UAE multi-center cohort"],"prefix":"10.1038","volume":"4","author":[{"given":"Naveed","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuhaleeqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema Mohammed Al","family":"Kaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Alzein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainul","family":"Aabideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydah M.","family":"Al-Awadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azmat Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imrana","family":"Afrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq Ahmed","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussab","family":"Damlaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama Taher","family":"Anaam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Hassan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad","family":"ElGhazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayane","family":"Mheidly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"239_CR1","first-page":"505","volume":"31","author":"SR Spellman","year":"2025","unstructured":"Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon Y-T, et al. Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy \u2013 a report from the CIBMTR. Transpl Cell Ther. 2025;31:505\u201332.","journal-title":"Transpl Cell Ther"},{"key":"239_CR2","doi-asserted-by":"crossref","unstructured":"Sharma SK. Indications for Allogeneic Stem Cell Transplant. In: Basics of Hematopoietic Stem Cell Transplant. Springer Nature Singapore: Singapore, 2023, pp 399\u2013410.","DOI":"10.1007\/978-981-19-5802-1_26"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","volume":"60","author":"JR Passweg","year":"2025","unstructured":"Passweg JR, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T, et al. The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT. Bone Marrow Transpl. 2025;60:519\u201328.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813\u201326.","journal-title":"N Engl J Med"},{"key":"239_CR5","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation. Biol Blood Marrow Transplant. 2015;21:1863\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bmt.2012.5","volume":"47","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transpl. 2012;47:337\u201341.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.3324\/haematol.2024.285002","volume":"109","author":"Y Atsuta","year":"2024","unstructured":"Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, et al. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica. 2024;109:3282\u201394.","journal-title":"Haematologica"},{"key":"239_CR8","unstructured":"Humaid O. Al-Shamsi. Establishing and launching a comprehensive bone marrow transplant unit in the UAE amidst the COVID-19 pandemic: overcoming barriers through international collaboration and Resilience. In: https:\/\/connection.asco.org\/blogs\/establishing-and-launching-comprehensive-bone-marrow-transplant-unit-uae-amidst-covid-19."},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"e41244","DOI":"10.1097\/MD.0000000000041244","volume":"104","author":"Y-C Wen","year":"2025","unstructured":"Wen Y-C, Wang Y-L, Pai L-N, Yang S-H, Chang T-Y, Chen S-H, et al. Word-of-mouth referrals between patients are a critical component of medical tourism for pediatric hematopoietic cell transplantation. Medicine. 2025;104:e41244.","journal-title":"Medicine"},{"key":"239_CR10","doi-asserted-by":"publisher","unstructured":"Syed N, Afrooz I, Mir FA, Khan AA, Abdulla NJMH, Hussain S. et al. High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching. Int J Hematol Oncol Stem Cell Res. 2025. https:\/\/doi.org\/10.18502\/ijhoscr.v19i2.18551.","DOI":"10.18502\/ijhoscr.v19i2.18551"},{"key":"239_CR11","doi-asserted-by":"publisher","unstructured":"Carreras E, Dufour C, Mohty M, Kr\u00f6ger N (eds.). The EBMT Handbook. Springer International Publishing: Cham, 2019. https:\/\/doi.org\/10.1007\/978-3-030-02278-5.","DOI":"10.1007\/978-3-030-02278-5"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR13","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood.V126.23.3154.3154","volume":"126","author":"ac harris","year":"2015","unstructured":"harris ac, young r, devine sm, hogan wj, ayuk f, bunworasate u, et al. guidelines for the standardization of acute graft-versus-host disease clinical data collection: an international consensus report. Blood. 2015;126:3154.","journal-title":"Blood"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. the 2014 diagnosis and staging working group report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.e1.","journal-title":"Biol Blood Marrow Transpl"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT\u2212NIH\u2212CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401\u201315.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR16","doi-asserted-by":"publisher","unstructured":"Kanakkande Kandy ZA, Nivargi S, Chaudhary B, Ramzan M, Abdullah F, Aboobacker F. et al. Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) From Matched Related Donors in Pediatric Patients: Insights From a Single Center in the United Arab Emirates. Cureus 2025. https:\/\/doi.org\/10.7759\/cureus.89239.","DOI":"10.7759\/cureus.89239"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbmt.2017.04.018","volume":"23","author":"P Khandelwal","year":"2017","unstructured":"Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, et al. Hematopoietic stem cell transplantation activity in pediatric cancer between 2008 and 2014 in the united states: a center for international blood and marrow transplant research report. Biol Blood Marrow Transplant. 2017;23:1342\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR18","doi-asserted-by":"publisher","first-page":"e0204914","DOI":"10.1371\/journal.pone.0204914","volume":"13","author":"S Hierlmeier","year":"2018","unstructured":"Hierlmeier S, Eyrich M, W\u00f6lfl M, Schlegel P-G, Wiegering V. Early and late complications following hematopoietic stem cell transplantation in pediatric patients \u2013 A retrospective analysis over 11 years. PLoS One. 2018;13:e0204914.","journal-title":"PLoS One"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2017-07-795948","volume":"130","author":"T Zuckerman","year":"2017","unstructured":"Zuckerman T. Allogeneic transplant: does age still matter?. Blood. 2017;130:1079\u201380.","journal-title":"Blood"},{"key":"239_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.24246","volume":"91","author":"H Kantarjian","year":"2016","unstructured":"Kantarjian H. Acute myeloid leukemia\u2014Major progress over four decades and glimpses into the future. Am J Hematol. 2016;91:131\u201345.","journal-title":"Am J Hematol"},{"key":"239_CR21","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1002\/cam4.5461","volume":"12","author":"N Stabellini","year":"2023","unstructured":"Stabellini N, Tomlinson B, Cullen J, Shanahan J, Waite K, Montero AJ, et al. Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival. Cancer Med. 2023;12:6711\u201321.","journal-title":"Cancer Med"},{"key":"239_CR22","first-page":"83","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"239_CR23","doi-asserted-by":"publisher","unstructured":"Blanco E, Izotova N, Booth C, Thrasher AJ. Immune reconstitution after gene therapy approaches in patients with X-linked severe combined immunodeficiency disease. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.608653.","DOI":"10.3389\/fimmu.2020.608653"},{"key":"239_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transpl. 2017;52:811\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-Haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.12659\/AOT.915381","volume":"24","author":"C Zhu","year":"2019","unstructured":"Zhu C, Chen G, Zhou W, Hou C, Wang X, Wang F, et al. Outcome and prognostic factors of high-risk acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Ann Transpl. 2019;24:328\u201340.","journal-title":"Ann Transpl"},{"key":"239_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92107-4","volume":"15","author":"M Tatari","year":"2025","unstructured":"Tatari M, Kasaeian A, Mousavian A-H, Oskouie IM, Yazdani A, Mousavi SA, et al. Prognostic factors for survival after allogeneic transplantation in acute myeloid leukemia in Iran using censored quantile regression model. Sci Rep. 2025;15:9055.","journal-title":"Sci Rep"},{"key":"239_CR28","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2023-185940","volume":"142","author":"J Chen","year":"2023","unstructured":"Chen J, Wang Z, Liu Q, Zhou H. Allo-HSCT improved outcome of high risk ALL in pediatric-inspired PDT-ALL-2016 Cohort. Blood. 2023;142:2229.","journal-title":"Blood"},{"key":"239_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbmt.2011.10.031","volume":"18","author":"NS Majhail","year":"2012","unstructured":"Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, et al. Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012;18:861\u201373.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJM199309163291204","volume":"329","author":"G Lucarelli","year":"1993","unstructured":"Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329:840\u20134.","journal-title":"N Engl J Med"},{"key":"239_CR31","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","volume":"130","author":"J Heimall","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post\u2013hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130:2718\u201327.","journal-title":"Blood"},{"key":"239_CR32","first-page":"S49","volume":"30","author":"M Nishitani","year":"2024","unstructured":"Nishitani M, Graham R-AT, Wang T, DeVos JD, Lee SJ, Spellman SR, et al. Graft Vs Host Disease (GVHD) in Pediatric Hematopoietic Stem Cell Transplant (HCT) recipients and impact on overall survival: a CIBMTR analysis. Transpl Cell Ther. 2024;30:S49\u2013S50.","journal-title":"Transpl Cell Ther"},{"key":"239_CR33","volume":"2014","author":"U Holtick","year":"2014","unstructured":"Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, et al. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev. 2014;2014:CD010189.","journal-title":"Cochrane Database Syst Rev"},{"key":"239_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367:1487\u201396.","journal-title":"N Engl J Med"},{"key":"239_CR35","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00277-024-05737-5","volume":"103","author":"BK Kim","year":"2024","unstructured":"Kim BK, Hong KT, Choi JY, Kim H, Park HJ, Kang HJ. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients. Ann Hematol. 2024;103:2051\u20138.","journal-title":"Ann Hematol"},{"key":"239_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1182\/blood.2019000216","volume":"134","author":"GDE Cuvelier","year":"2019","unstructured":"Cuvelier GDE, Nemecek ER, Wahlstrom JT, Kitko CL, Lewis VA, Schechter T, et al. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria. Blood. 2019;134:304\u201316.","journal-title":"Blood"},{"key":"239_CR37","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1182\/blood-2018-99-111764","volume":"132","author":"HT Greinix","year":"2018","unstructured":"Greinix HT, Eikema D-J, Koster L, Penack O, Yakoub-Agha I, Montoto S, et al. Incidence of acute graft-versus-host disease and survival after allogeneic hematopoietic cell transplantation over time: a study from the transplant complications and chronic malignancies working party of the EBMT. Blood. 2018;132:2120.","journal-title":"Blood"},{"key":"239_CR38","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","volume":"35","author":"BL Scott","year":"2017","unstructured":"Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2017;35:1154\u201361.","journal-title":"J Clin Oncol"},{"key":"239_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41409-022-01865-6","volume":"58","author":"C Luo","year":"2023","unstructured":"Luo C, Wu G, Huang X, Ding Y, Huang Y, Song Q, et al. Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis. Bone Marrow Transpl. 2023;58:175\u201385.","journal-title":"Bone Marrow Transpl"},{"key":"239_CR40","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3324\/haematol.2020.265769","volume":"107","author":"H Greinix","year":"2021","unstructured":"Greinix H, Eikema D-J, Koster L, Penack O, Yakoub-Agha I, Montoto S, et al. Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study. Haematologica. 2021;107:1054\u201363.","journal-title":"Haematologica"},{"key":"239_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","volume":"2008","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Flowers MED. Recognizing and managing chronic graft-versus-host disease. Hematology. 2008;2008:134\u201341.","journal-title":"Hematology"},{"key":"239_CR42","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbmt.2017.11.004","volume":"24","author":"M Qayed","year":"2018","unstructured":"Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, et al. Influence of age on acute and chronic GVHD in children undergoing HLA-identical sibling bone marrow transplantation for acute leukemia: implications for prophylaxis. Biol Blood Marrow Transplant. 2018;24:521\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"239_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/petr.12009","volume":"16","author":"M Faraci","year":"2012","unstructured":"Faraci M, Caviglia I, Biral E, Morreale G, Giardino S, Garbarino L, et al. Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr. Pediatr Transpl. 2012;16:887\u201393.","journal-title":"Pediatr Transpl"},{"key":"239_CR44","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/cells13181524","volume":"13","author":"A Olivieri","year":"2024","unstructured":"Olivieri A, Mancini G. Current approaches for the prevention and treatment of acute and chronic GVHD. Cells. 2024;13:1524.","journal-title":"Cells"},{"key":"239_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000490407","volume":"140","author":"J Wen","year":"2018","unstructured":"Wen J, Haque Q, Pei F, Chen L, Ruan Y, Liu X, et al. Transplant outcomes in beta-thalassemia major patients receiving combined granulocyte colony-stimulating factor-primed bone marrow and cord blood graft compared to granulocyte colony-stimulating factor-primed bone marrow alone. Acta Haematol. 2018;140:20\u20139.","journal-title":"Acta Haematol"},{"key":"239_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/1744666X.2017.1381558","volume":"13","author":"J Heimall","year":"2017","unstructured":"Heimall J, Cowan MJ. Long term outcomes of severe combined immunodeficiency: therapy implications. Expert Rev Clin Immunol. 2017;13:1029\u201340.","journal-title":"Expert Rev Clin Immunol"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00239-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00239-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00239-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:27:59Z","timestamp":1784032079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00239-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1038\/s44276-026-00239-5","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Sheikh Shakhbout Medical City Institutional Review Board, Abu Dhabi, United Arab Emirates (IRB No. SSMCREC-444; approved on 30 November 2022). All methods were performed in accordance with the relevant institutional guidelines and regulations. De-identified data were collected from participating centers, and the requirement for individual informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the author(s) used ChatGPT in order to improve the English language. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies"}}],"article-number":"36"}}